Global Next-Generation Oncology Devices and Solutions Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global next-generation oncology devices and solutions market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, end user, and region. The global market for next-generation oncology devices and solutions can be segmented by type: devices, software. The software segment held the largest revenue share in 2022. Next-generation oncology devices and solutions market is further segmented by application: breast cancer, lung cancer, prostate cancer, others. Among these, the breast cancer segment was accounted for the highest revenue generator in 2022. Based on end user, the next-generation oncology devices and solutions market is segmented into: diagnostic imaging centers, hospitals, others. The hospitals segment captured the largest share of the market in 2022. On the basis of region, the next-generation oncology devices and solutions market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global next-generation oncology devices and solutions market.
Market Segmentation
By type: devices, software
By application: breast cancer, lung cancer, prostate cancer, others
By end user: diagnostic imaging centers, hospitals, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The market research report covers the analysis of key stake holders of the global next-generation oncology devices and solutions market. Some of the leading players profiled in the report include Accuray Incorporated, E.ON SE, Elekta AB, Koninklijke Philips N.V., Siemens AG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global next-generation oncology devices and solutions market.
To classify and forecast the global next-generation oncology devices and solutions market based on type, application, end user, region.
To identify drivers and challenges for the global next-generation oncology devices and solutions market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global next-generation oncology devices and solutions market.
To identify and analyze the profile of leading players operating in the global next-generation oncology devices and solutions market.
Why Choose This Report
Gain a reliable outlook of the global next-generation oncology devices and solutions market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TYPE
Devices
Software
PART 6. MARKET BREAKDOWN BY APPLICATION
Breast cancer
Lung cancer
Prostate cancer
Others
PART 7. MARKET BREAKDOWN BY END USER
Diagnostic imaging centers
Hospitals
Others
PART 8. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 9. KEY COMPANIES
Accuray Incorporated
E.ON SE
Elekta AB
Koninklijke Philips N.V.
Siemens AG
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View ReportGlobal Next-Generation Optical Fiber Market 2023
The medical implant market is poised for substantial growth, with a projected increase from USD 173.6 billion in 2022 to USD 276.9 billion by 2029, reflecting a CAGR of 6.6%
USD 2850 View ReportGlobal Next-Generation Automotive Lighting Market 2023-2029
Next-generation automotive lighting refers to advanced lighting technologies that are being developed and implemented in modern vehicles. These technologies aim to improve visibility, safety, and energy efficiency while also providing
USD 2650 View ReportFill The Form For Sample Request